Target intelligence / Profile preview

Oral biofilm pH modulation

Molecular classification
Other
01

Overview

"Oral biofilm pH modulation" refers to the dynamic regulation of acidity (pH) within dental biofilms (microbial communities adhering to teeth). The biofilm microenvironment includes highly localized acidic pockets driven by acidogenic bacteria (notably *Streptococcus mutans*), which are major contributors to dental caries due to sustained exposure of enamel to pH values below the critical threshold for demineralization (generally pH < 5.5)[1][4][7]. Salivary buffering, bacterial ammonia generation, and host or therapeutic interventions can increase microenvironmental pH, shifting the balance away from cariogenic (disease-causing) species and favoring remineralization and oral health[2][5]. Modulating the pH of oral biofilms, including through pH-activated antimicrobials, represents a therapeutic approach rather than a singular molecular target[3][5]. The relevant mechanisms involve acid-base chemistry, microbial metabolism, and matrix compartmentalization, not action at a specific protein or receptor[1][3][4][5][7].

Other names
Modulation of oral biofilm pHOral biofilm acid-base balanceOral plaque pH regulation
02

Mechanism of action

pH-responsive drug release/destruction of acidic biofilms[3]; Buffering and neutralization of acid[2][5]; Modulation of biofilm composition and virulence via environmental pH[2][5]

03

Biological functions

Biofilm formation and architectureEnvironmental pH regulationMaintenance of microbial community balanceAcid-base bufferingTooth enamel demineralization and remineralization
04

Disease associations

Dental cariesPeriodontitisOther oral infections
05

Safety considerations

Non-specific disruption of oral microbiota leading to loss of beneficial microbesRisk of insufficient neutralization of acid, promoting caries and enamel demineralizationLocal irritation or toxicity for some pH-activated agents
06

Interacting drugs

pH-activated antimicrobials (e.g., pH-sensitive drug delivery nanoparticles, acid-activated agents)

2 more in the full profile.

07

Biomarkers

Biofilm pH profile (e.g., measurement of acidic "pockets" within the biofilm)Activity of pH-buffering enzymes (e.g., carbonic anhydrase VI)Proportion of acidogenic/aciduric bacteria (e.g., *Streptococcus mutans*)

Beyond the preview

Go deeper on Oral biofilm pH modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral biofilm pH modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call